A nurse is assessing a 28-year-old patient who presents with jaundice, dark urine, and clay-colored stools. Laboratory results show elevated ALT (450 U/L), AST (380 U/L), and total bilirubin (8.2 mg/dL). The patient reports recent travel to Southeast Asia and consumption of raw shellfish. Which assessment finding would be MOST indicative of hepatitis A infection?
1Positive anti-HAV IgM antibodies with negative HBsAg and anti-HCV antibodies✓ 정답
2Elevated alpha-fetoprotein levels with positive hepatitis B surface antigen
3Presence of hepatitis D RNA with concurrent hepatitis C infection
4Positive anti-HCV antibodies with detectable HCV RNA and normal anti-HAV IgG
해설
Anti-HAV IgM is diagnostic for acute hepatitis A, consistent with travel and raw shellfish exposure. Other options indicate hepatitis B, C, or D, which are not supported by the patient's presentation.
Clinical Presentation and Laboratory Findings
The patient’s triad of jaundice, dark urine, and clay-colored stools points directly to a problem with bilirubin metabolism, which is a hallmark of hepatocellular injury. In this case, the markedly elevated transaminases—ALT at 450 U/L and AST at 380 U/L—indicate significant hepatocyte inflammation and necrosis. The total bilirubin of 8.2 mg/dL confirms clinical jaundice, while the presence of dark urine (from excess conjugated bilirubin excreted by the kidneys) and clay-colored stools (from a lack of bilirubin reaching the gastrointestinal tract) suggests intrahepatic cholestasis secondary to the inflammatory process. When a patient with this clinical picture reports recent travel to an endemic region like Southeast Asia and a history of consuming raw shellfish, a classic vehicle for hepatitis A virus (HAV), the clinical suspicion for an acute HAV infection becomes very high .
Interpretation of Serological Markers
The most definitive way to diagnose an acute HAV infection is through serological testing. The correct answer is the presence of positive anti-HAV IgM antibodies. In the context of acute viral hepatitis, IgM antibodies are the first to appear and are the gold standard for diagnosing a recent or ongoing infection. The simultaneous finding of negative HBsAg and negative anti-HCV antibodies is equally critical, as it effectively rules out acute or chronic hepatitis B and hepatitis C as the cause of the patient’s symptoms. This pattern of isolated positive anti-HAV IgM is pathognomonic for acute hepatitis A. It is important to distinguish this from anti-HAV IgG, which appears later and indicates past infection or vaccination, conferring lifelong immunity .
Analysis of Incorrect Options
The other options describe serological profiles for fundamentally different hepatic conditions, which are not consistent with the patient's risk factors and acute presentation.
- Option 2, with an elevated alpha-fetoprotein (AFP) and positive HBsAg, is a profile concerning for hepatocellular carcinoma (HCC) in the setting of chronic hepatitis B infection. This is a chronic, progressive condition, not an acute illness following raw shellfish consumption.
- Option 3 describes a co-infection with hepatitis D virus (HDV) and hepatitis C virus (HCV). HDV is a defective virus that requires the presence of HBsAg to replicate; it cannot cause a co-infection with HCV alone. This profile is biologically implausible.
- Option 4, with positive anti-HCV antibodies and detectable HCV RNA, confirms an active hepatitis C infection. The presence of normal anti-HAV IgG would indicate past immunity to HAV, not an acute infection. This profile points to a diagnosis of hepatitis C, which is primarily transmitted via bloodborne routes, not the fecal-oral route associated with contaminated food and water.
Epidemiological Context and Clinical Reasoning
The patient’s history is a powerful clinical clue that aligns with the serological diagnosis. The epidemiological landscape of hepatitis A is shifting, and understanding this is key for NCLEX-RN clinical judgment. As sanitation improves in many parts of the world, fewer children are exposed to HAV, leading to a larger pool of susceptible adults . When these non-immune adults travel to endemic regions, such as Southeast Asia, and ingest contaminated food or water—like raw shellfish, which are filter-feeders that concentrate the virus—they are at high risk for developing a severe, symptomatic acute infection. This contrasts with childhood infections, which are often mild or asymptomatic. Therefore, the combination of a compatible exposure history, classic symptoms of acute hepatitis, and a serological panel confirming acute HAV while excluding other hepatotropic viruses provides the strongest evidence for the diagnosis .
Clinical Approach to Suspected Acute Hepatitis A
When a patient presents with jaundice, markedly elevated transaminases, and a history of travel to endemic regions or consumption of raw shellfish, prioritize serological testing for acute hepatitis A. The diagnostic cornerstone is a positive anti-HAV IgM result. Simultaneously, rule out other common viral hepatitides with HBsAg and anti-HCV. This targeted panel provides a definitive diagnosis and guides public health reporting, as hepatitis A is a nationally notifiable disease.
Key Diagnostic Steps
Order hepatitis panel: anti-HAV IgM, HBsAg, anti-HCV. A positive IgM with negative others confirms acute HAV.
Assess liver function: ALT, AST, total/direct bilirubin, alkaline phosphatase, and INR to evaluate severity.
Obtain a detailed exposure history: travel, seafood consumption, childcare attendance, or close contact with a confirmed case.
Nursing Management and Patient Education
Implement standard precautions; contact precautions are not routinely required unless the patient is incontinent or diapered.
Educate on strict hand hygiene, especially after toileting, to prevent fecal-oral spread to household contacts.
Advise against alcohol and hepatotoxic medications (e.g., acetaminophen) during the acute phase to minimize further liver injury.
Recommend post-exposure prophylaxis (hepatitis A vaccine or immune globulin) for unvaccinated close contacts within 2 weeks of exposure.
Counsel that full clinical recovery may take weeks to months, but chronic infection does not occur with HAV.
Anti-HAV IgM — Immunoglobulin M antibody against hepatitis A virus; its presence indicates acute or recent HAV infection and is the gold standard for diagnosis.
HBsAg — Hepatitis B surface antigen; a marker of active hepatitis B infection, either acute or chronic.
ALT/AST — Alanine aminotransferase and aspartate aminotransferase; liver enzymes released into the bloodstream during hepatocyte injury or necrosis.
Intrahepatic cholestasis — Impaired bile flow within the liver leading to accumulation of bile acids and bilirubin, causing jaundice, dark urine, and clay-colored stools.
Fecal-oral transmission — Route of transmission for hepatitis A, often through ingestion of contaminated food or water, including raw shellfish from endemic areas.